Physician profile
Mariya Bourget
NPI 1477870541
$5,224.09
in general payments reported to CMS, 2019-2025
49 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $1,548 · 2021: $833 · 2022: $460 · 2023: $488 · 2024: $585 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $852.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $713.86 | 2019-2025 | Airsupra, Breztri |
| Esperion Therapeutics, INC. | $249.05 | 2021-2024 | Nexletol, Nexlizet |
| Amgen INC. | $228.93 | 2019-2024 | Otezla, Repatha |
| Lilly USA, LLC | $215.90 | 2019-2024 | Zepbound, Mounjaro |
| Sunovion Pharmaceuticals INC. | $162.63 | 2019-2020 | |
| Allergan, INC. | $156.43 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.48 | 2019-2024 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $153.24 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $144.86 | 2019-2021 | |
| Qorumpartners | $143.26 | 2022 | |
| Emd Serono, INC. | $142.36 | 2020-2021 | |
| Abbvie INC. | $132.22 | 2019-2023 | Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $120.50 | 2019-2022 | |
| Exact Sciences Corporation | $101.74 | 2023-2024 | Cologuard Collection Kit |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariya Bourget listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.